Showing results (1061-1070 of 1,194) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|November 4, 2017
Some statistical considerations in the clinical development of cancer immunotherapiesBo HuangPharmaceutical Statistics|March 13, 2016
A win ratio approach to comparing continuous non-normal outcomes in clinical trialsDuolao Wang, Stuart PocockPharmaceutical Statistics|January 4, 2018
Development of predictive signatures for treatment selection in precision medicine with survival outcomesYu-Chuan Chen, Un Jung Lee, Chen-An Tsai, et al.Pharmaceutical Statistics|October 22, 2020
Utilizing Bayesian predictive power in clinical trial designOfir Harari, Grace Hsu, Louis Dron, et al.Pharmaceutical Statistics|October 26, 2020
Resampling-based stepwise multiple testing procedures with applications to clinical trial dataJiwei He, Feng Li, Yan Gao, et al.Pharmaceutical Statistics|June 23, 2022
A MCP-Mod approach to designing and analyzing survival trials with potential non-proportional hazardsXiaodong Luo, Yuan Sun, Zhixing XuPharmaceutical Statistics|January 10, 2023
Natural cubic splines for the analysis of Alzheimer's clinical trialsMichael C Donohue, Oliver Langford, Philip S Insel, et al.Pharmaceutical Statistics|December 30, 2022
An improved score-type confidence interval for stratified risk differences involving rare eventsYetao Hu, Kaifeng Lu, Lei Xie, et al.Pharmaceutical Statistics|January 13, 2023
Setting the control limit at release for stability assuranceX Gregory Chen, A W van der VaartPharmaceutical Statistics|November 23, 2022
Should responder analyses be conducted on continuous outcomes?Robert Abugov, Jennifer Clark, Laura Higginbotham, et al.Pageof 120